Carbonic anhydrase is a vital enzyme found in the body, classified as a metalloenzyme due to its zinc 2+ content. The enzyme plays a critical role in converting carbon dioxide into bicarbonate and a proton through a reversible dehydration and hydration reaction, aiding in the elimination of CO2 from the lungs. Additionally, carbonic anhydrase helps maintain a healthy pH balance, regulate ions, and facilitate gas exchange in the body.

In the human body, carbonic anhydrase exists in twelve catalytic and three non-catalytic isoforms. While the catalytic isoforms possess Zn2+ in their active sites, non-catalytic isoforms lack this metallic element. Each isoform has a unique amino acid sequence, leading to different physiological functions and locations within the body. Carbonic anhydrase can be found in various parts of the body, such as the cytosol, mitochondria, membrane-bound, and secreted. Examples of cytosolic carbonic anhydrase isoform include carbonic anhydrase (hCA) I-III, VII, and XIII.

One of the most well-known isoforms of carbonic anhydrase is hCA II, found in the cell's cytosol. The enzyme's active site contains a hydrophobic and hydrophilic region, each with specific amino acid sequences that play an essential role in the enzyme's catalytic function. The enzyme's active site pocket houses a Zn2+ that connects to three histidine molecules and a solvent molecule. Although histidine is present in every isoform, the polar and nonpolar surface regions of the enzyme vary.

Carbonic anhydrase follows a ping-pong sequence, requiring products to release before the next substrate binds. In the first step of the reaction, carbon dioxide binds to the enzyme's active site. One of the oxygen atoms from carbon dioxide attaches to threonine, displacing a water molecule, while the other oxygen binds between zinc and valine. The hydrophobic region facilitates nucleophilic attack, converting carbon dioxide to zinc-bicarbonate. Zinc hydroxide formation occurs when a proton transfers from Zn-H2O previously made.

In human cells, the carbonic anhydrase transduction pathway is complex, involving multiple enzymes and proteins. In conclusion, carbonic anhydrase plays a critical role in human physiology, maintaining bodily functions such as gas exchange, ion regulation and pH balance.

The role of carbonic anhydrase in regulating pH balance and fluid balance in various parts of human physiology is significantly crucial, as demonstrated through numerous examples. In the field of medicine, inhibitors of carbonic anhydrase have been developed to treat several conditions such as hypertension, epilepsy, and congestive heart failure. There have also been inhibitors designed to combat glaucoma, a condition where fluid buildup in the eye can cause damage to the optic nerve and result in vision loss. In the case of glaucoma, inhibitors of carbonic anhydrase reduce the production of the aqueous humor, which in turn reduces the rate of bicarbonate ion conversion and prevents the buildup of pressure within the eye. Carbonic anhydrase inhibitors have also been used in the kidneys to prevent the reabsorption of bicarbonate in the tubular cells and allow for increased urine excretion and reduced water retention, acting as diuretics that can lower blood pressure.

One fascinating area of study is the use of carbonic anhydrase in biotechnology, particularly in the development of an artificial lung that could help those with respiratory distress. The hope is that an artificial lung could work more efficiently than a traditional ventilator, but scientists must address the challenge of how to maintain the catalytic function of carbonic anhydrase when facilitating CO2 transfer. In the blood mixing component of the device, the mechanical force applied can denature the carbonic anhydrase, which would prevent CO2 from being converted to bicarbonate for efficient transport in the body. To overcome this, researchers are working to create a biosynthetic form of carbonic anhydrase that would be more stable than the naturally occurring version.

References:

1. Lindskog, S. (1997). Structure and mechanism of carbonic anhydrase. Pharmacology & therapeutics, 74(1), 1-20.

2. Esbaugh, A. J., & Tufts, B. L. (2006). The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates. Respiratory physiology & neurobiology, 154(1-2), 185-198.

3. Gilmour, K. M. (2011). Transport and exchange of respiratory gases in the blood. Encyclopedia of fish physiology, 899-900.

4. Kleinman, L., Petering, H., & Sutherland, J. (1967). Blood Carbonic anhydrase activity and zinc concentration in infants with respiratory-distress syndrome. New England Journal of Medicine, 227, 1157-1161.

5. Aggarwal, M., Boone, C. D., Kondeti, B., & McKenna, R. (2013). Structural annotation of human carbonic anhydrases. Journal of enzyme inhibition and medicinal chemistry, 28(2), 267-277.

6. Vullo, D., Franchi, M., Gallori, E., Antel, J., Scozzafava, A., & Supuran, C. T. (2004). Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. Journal of medicinal chemistry, 47, 1272-1279.

1. Krishnamurthy VM, Kaufman GK, Urbach AR, Gitlin I, Gudiksen KL, Weibel DB, et al. Carbonic anhydrase represents an ideal model for studying the biophysics and physical-organic characteristics of proteins and the binding of proteins to ligands. Chem Rev. 2008;108(3):946–1051.

2. Lindskog S. Carbonic anhydrase: structure and mechanism. Pharmacol Ther. 1997;74(1):1-20.

3. Warrillow S. Carbonic anhydrase inhibitors. In: Ronco C, Bellomo R, Kellum JA, editors. Critical Care Nephrology. 2nd ed. Philadelphia, PA: Saunders; 2009: 566-568.

4. Becker HM. Carbonic anhydrase IX and cancer acid transport. Br J Cancer. 2020;122(2):157-167.

5. Aslam S, Gupta V. Carbonic Anhydrase Inhibitors [Updated 2022 Apr 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557736/

6. Kassamali R, Sica DA. Acetazolamide: a forgotten diuretic. Cardiol Rev. 2011;19(6):276-278.

7. Arazawa DT, Oh HI, Ye SH, Johnson CA Jr, Woolley JR, Wagner WR, Federspiel WJ. CO₂ removal from blood is accelerated via immobilized carbonic anhydrase on hollow fiber membranes. J Membr Sci. 2012;404:25–31.

8. Wilson C. Backpack with artificial lungs offers new hope to people with lung failure. New Scientist. 2017 Mar 21. Issue 3118. https://www.newscientist.com/article/2125422-artificial-lungs-in-a-backpack-may-free-people-with-lung-failure/

9. Smith GD, Harrison R, Eisenthal R. Determination of half-reaction equilibrium in a ping-pong enzyme mechanism. Neurochem Res. 1996;21(9):1061-1064. doi: 10.1007/BF02532416. PMID: 8897469.